Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cerilliant
Farmers Insurance
Chinese Patent Office
Cantor Fitzgerald
Mallinckrodt
UBS
Accenture
Fuji

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 006931

« Back to Dashboard

NDA 006931 describes SYNCURINE, which is a drug marketed by Glaxosmithkline and is included in one NDA. Additional details are available on the SYNCURINE profile page.

The generic ingredient in SYNCURINE is decamethonium bromide. Additional details are available on the decamethonium bromide profile page.
Summary for 006931
Tradename:SYNCURINE
Applicant:Glaxosmithkline
Ingredient:decamethonium bromide
Patents:0
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength1MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Medtronic
QuintilesIMS
Farmers Insurance
Express Scripts
Colorcon
Julphar
Fuji
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.